Regulation of NF-κB activity by IκBα and IκBβ stability

Immunobiology

Volumn 198, Issue 1-3, 1997, Pages 3-13

  Krappmann, Daniel ^a   Scheidereit, Claus ^a  

^a MAX DELBRÜCK CENTER FOR MOLECULAR MEDICINE   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; PROTEASOME;

ARTICLE; B LYMPHOCYTE; HALF LIFE TIME; HELA CELL; HUMAN; HUMAN CELL; IMMUNOREGULATION; PRIORITY JOURNAL; PROTEIN METABOLISM; SIGNAL TRANSDUCTION;

EID: 0031466171     PISSN: 01712985     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0171-2985(97)80022-8     Document Type: Article

References (43)

1. VERMA, I. M., J. K. STEVENSON, E. M. SCHWARZ, D. VAN ANTWERP, and S. MIYAMOTO. 1995. Rel/NF-κB/IκB family: intimate tales of association and dissociation. Genes Dev. 9: 2723.
2. BALDWIN, A. S. Jr. 1996. The NF-κB and IκB proteins: New discoveries and insights. Annu. Rev. Immunol. 14: 649.
3. BAEUERLE, P. A., and D. BALTIMORE. 1996. NF-κB: Ten years after. Cell 87: 13-20.
4. WULCZYN, F. G., D. KRAPPMANN, and C. SCHEIDEREIT. 1996. The NF-κB-/Rel and IκB gene families: mediators of immune response and inflammation. J. Mol. Med. 74: 749.
5. BROCKMAN, J. A., D. C. SCHERER, T. A. MCKINSEY, S. M. HALL, X. QI, W. Y. LEE, and D. W. BALLARD. 1995. Coupling of a signal response domain in IκBα to multiple pathways for NF-κB activation. Mol. Cell. Biol. 15: 2809.
6. BROWN, K., S. GERSTBERGER, L. CARLSON, G. FRANZOSO, U. SIEBENLIST. 1995. Control of IκBα proteolysis by site-specific, signal-induced phosphorylation. Science 267: 1485.
7. TRAENCKNER, E. B., H. L. PAHL, T. HENKEL, K. N. SCHMIDT, S. WILK, and P. A. BAEUERLE. 1995. Phosphorylation of human IκBα on serines 32 and 36 controls IκBα proteolysis and NF-κB activation in response to diverse stimuli. EMBO J. 14: 2876.
8. WHITESIDE, S. T., M. K. ERNST, O. LEBAIL, C. LAURENT-WINTER, N. RICE, and A. ISRAËL. 1995. N- and C-terminal sequences control degradation of MAD3/IκBα in response to inducers of NF-κB activity. Mol. Cell. Biol. 15: 5339.
9. CHEN, Z., J. HAGLER, V. J. PALOMBELLA, F. MELANDRI, D. SCHERER, D. W. BALLARD, and T. MANIATIS. 1995. Signal-induced site-specific phosphorylation targets IκBα to the ubiquitin-proteasome pathway. Genes Dev. 9: 1586.
10. SCHERER, D. C., J. A. BROCKMAN, Z. J. CHEN, T. MANIATIS, and D. W. BALLARD. 1995. Signal-induced degradation of IκBα requires site-specific ubiquitination. Proc. Natl. Acad. Sci. U.S.A. 92: 11259.
11. BALDI, L., K. BROWN, U., and SIEBENLIST. 1996. Critical role for lysine 21 and 22 in signal-induced, ubiquitin-mediated proteolysis of IκBα. J. Biol. Chem. 271: 376.
12. IMBERT, V., R. A. RUPEC, A. LIVOLSI, H. L. PAHL, E. B.-M. TRAENCKNER, C. MUELLER-DIECKMANN, D. FARAHIFAR, B. ROSSI, P. AUBERGER, P. A. BAEUERLE, and J.-F. PEYRON. 1996. Tyrosine phosphorylation of IκBα activates NF-κB without proteolytic degradation of IκBα. Cell 86: 787.
13. SINGH, S., B. G. DARNAY, and B. B. AGGARWAL. 1997. Site-specific tyrosine phosphorylation of IκBα negatively regulates its inducible phosphorylation and degradation. J. Biol. Chem. 271: 31049.
14. HATADA, E. N., M. NAUMANN, and C. SCHEIDEREIT. 1993. Common structural constituents confer IκB-activity to NF-κB-p105 and IκB/MAD-3. EMBO J. 12: 2781.
15. ERNST, M. K., L. L. DUNN, and N. R. RICE. 1995. The PEST-like sequence of IκBα is responsible for inhibition of DNA binding but not for cytoplasmic retention of c-Rel or RelA homodimers. Mol. Cell. Biol. 15: 872.
16. KRAPPMANN, D., F. G., WULCZYN, and C. SCHEIDEREIT. 1996. Different mechanisms control signal-induced degradation and basal turnover of the NF-κB inhibitor IκBα in vivo. EMBO J. 15: 6716.
17. RICE, N. R., and M. K. ERNST. 1993. In vivo control of NF-κB activation by IκBα. EMBO J. 12: 4685.
18. MIYAMOTO, S., P. J. CHIAO, and I. M. VERMA. 1994. Enhanced IκBα degradation is responsible for constitutive NF-κB activity in mature murine B-cell lines. Mol. Cell. Biol. 14: 3276.
19. SCOTT, M. L., T. FUJITA, H. C. LIOU, G. P. NOLAN, and D. BALTIMORE. 1993. The p65 subunit of NF-κB regulates IκB by two distinct mechanisms. Genes Dev. 7: 1266.
20. MCELHINNY, J. A., S. A. TRUSHIN, G. D. BREN, N. CHESTER, and C. V. PAYA. 1996. Casein kinase II phosphorylates IκBα as S-283, S-289, S-293 and T-291 and is required for its degradation. Mol. Cell. Biol. 16: 899.
21. SCHWARZ, E. M., D. VAN ANTWERP, and I. M. VERMA. 1996. Constitutive phosphorylation of IκBα by casein kinase II occurs preferentially at serine 293: Requirement for degradation of free IκBα. Mol. Cell. Biol. 16: 3554.
22. THOMPSON, J. E., R. J. PHILLIPS, H. ERDJUMENT-BROMAGE, P. TEMPST, and S. GHOSH. 1995. IκBβ regulates the persistent response in a biphasic activation of NF-κB. Cell 80: 573.
23. DIDONATO, J., F. MERCURIO, C. ROSETTE, J. WU-LI, H. SUYANG, S. GHOSH, and M. KARIN. 1996. Mapping of the inducible IκB phosphorylation sites that signal its ubiquitination and degradation. Mol. Cell. Biol. 16: 1295.
24. MCKINSEY, T. A., J. A. BROCKMAN, D. C. SCHERER, S. W. AL-MURRANI, P. L. GREEN, and D. W. BALLARD. 1996. Inactivation of IκBβ by the tax protein of human T-cell leukemia virus type 1: a potential mechanism for constitutive induction of NF-κB. Mol. Cell. Biol. 16: 2083.
25. LINK, E., L. D. KERR, R. SCHRECK, U. ZABEL, I. M. VERMA, P. A. BAEUERLE. 1992. Purified IκBβ is inactivated upon dephosphorylation. J. Biol. Chem. 267: 239.
26. CHU, Z.-L., T. A. MACKINSEY, L. LIU, X. QI, and D. W. BALLARD. 1996. Basal phosphorylation of the PEST domain in IκBα regulates its functional interaction with the c-rel protooncogene product. Mol. Cell. Biol. 16: 5974.
27. JOHNSON, D. R., I. DOUGLAS, A. JAHNKE, S. GHOSH, and J. S. POBER. 1996. A sustained reduction in IκBβ may contribute to persistent NF-κB activation in human endothelial cells. J. Biol. Chem. 271: 16317.
28. GOOD, L., and S. C. SUN. 1996. Persistent activation of NF-κB/Rel by human T-cell leukemia virus type 1 tax involves degradation of IκBβ. J. Virol. 70: 2730.
29. BEG, A. A., W. C. SHA, R. T. BRONSON, and D. BALTIMORE. 1996. Constitutive activation, enhanced granulopoiesis and neonatal lethality in IκBα-deficient mice. Genes Dev. 9: 2736.
30. SUYANG, H., R. PHILLIPS, I. DOUGLAS, and S. GHOSH. 1996. Role of unphosphorylated, newly synthesized IκBβ in persistent activation of NF-κB. Mol. Cell. Biol. 16: 5444.
31. NAUMANN, M., and C. SCHEIDEREIT. 1994. Activation of NF-κB in vivo is regulated by multiple phosphorylations. EMBO J. 13: 4597.
32. MELLITS, K. H., R. T. HAY, and S. GOODBOURN. 1993. Proteolytic degradation of MAD3 (IκBα) and enhanced processing of the NF-κB precursor p105 are obligatory steps in the activation of NF-κB. Nucleic. Acids. Res. 21: 5059.
33. PALOMBELLA, V. J., O. J. RANDO, A. L. GOLDBERG, and T. MANIATIS. 1994. The ubiquitin-proteasome pathway is required for processing the NF-κB1 precursor protein and the activation of NF-κB. Cell 78: 773.
34. TRAENCKNER, E. B., S. WILK, and P. A. BAEUERLE. 1994. A proteasome inhibitor prevents activation of NF-κB. EMBO J. 13: 5433.
35. SEN, R., and D. BALTIMORE. 1986. Inducibility of the κ immunoglobulin enhancer-binding protein NF-κB by a posttranslational mechanism. Cell 47: 921.
36. BARGOU, R. C., C. LENG, D. KRAPPMANN, F. EMMERICH, M. Y. MAPARA, P. T. DANIEL, K. BOMMERT, C. SCHEIDEREIT, and B. DÖRKEN. 1996. High level nuclear NF-κB and Oct-2 activity are characteristic for Hodgkin's disease tumor cells. Blood 87: 4340.
37. BACHELERIE, F., J. ALCAMI, F. ARENZANA-SEISDEDOS, and J. L. VIRELIZIER. 1991. HIV enhancer activity perpetuated by NF-κB induction on infection of monocytes. Nature 350: 709.
38. KALTSCHMIDT, C., B. KALTSCHMIDT, H. NEUMANN, H. WEKERLE, and P. A. BAEUERLE. 1994. Constitutive NF-κB activity in neurons. Mol. Cell. Biol. 14: 3981.
39. DELUCA, C., A. ROULSTON, A. KOROMLAS, M. A. WAINBERG, and J. HISCOTT. 1996. Chronic human immunodeficiency virus type 1 infection of myeloid cells disrupts the autoregulatory control of the NF-κB/Rel pathway via enhanced IκBα degradation. J. Virol. 70: 5183.
40. GHOSH, S., and D. BALTIMORE. 1990. Activation in vitro of NF-κB by phosphorylation of its inhibitor IκB. Nature 344: 678.
41. KLEMENT, J. F., N. R. RICE, B. D. CAR, S. J. ABBONDANZO, G. D. POWERS, H. BHATT, C. CHEN, C. A. ROSEN, and C. L. STEWART. 1996. IκBα deficiency results in a sustained NF-κB response and severe widespread dermatitis in mice. Mol. Cell. Biol. 16: 2341.
42. ARENZANA-SEISDEDOS, F., J. THOMPSON, M. S. RODRIGUEZ, F. BACHELERIE, D. THOMAS, R. T. HAY. 1995. Inducible nuclear expression of newly synthesized IκBα negatively regulates DNA-binding activities of NF-κB. Mol. Cell. Biol. 15: 2689.
43. HOHMANN, H.-P., R. REMY, C. SCHEIDEREIT, A. P. G. M. VAN LOON. 1991. Maintenance of NF-κB activity is dependent on protein synthesis and the continuous presence of external stimuli. Mol. Cell. Biol. 11: 259.